Cargando…

Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms

Recent studies revealed that the activation of serotonergic 5-HT(1A) and muscarinic M(1), M(4), or M(5) receptors prevent MK-801-induced cognitive impairments in animal models. In the present study, the effectiveness of the simultaneous activation of 5-HT(1A) and muscarinic receptors at preventing M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cieślik, Paulina, Radulska, Adrianna, Burnat, Grzegorz, Kalinowski, Leszek, Wierońska, Joanna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395335/ https://www.ncbi.nlm.nih.gov/pubmed/34445318 http://dx.doi.org/10.3390/ijms22168612

Ejemplares similares

Activation of Metabotropic Glutamate Receptor (mGlu(2)) and Muscarinic Receptors (M(1), M(4), and M(5)), Alone or in Combination, and Its Impact on the Acquisition and Retention of Learning in the Morris Water Maze, NMDA Expression and cGMP Synthesis
por: Wierońska, Joanna M., et al.
Publicado: (2023)

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
por: Cieślik, Paulina, et al.
Publicado: (2021)

Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice
por: Cieślik, Paulina, et al.
Publicado: (2019)

Mutual activation of glutamatergic mGlu(4) and muscarinic M(4) receptors reverses schizophrenia-related changes in rodents
por: Cieślik, Paulina, et al.
Publicado: (2018)

Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia
por: Wierońska, Joanna M, et al.
Publicado: (2021)

Opposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex
por: Sparks, Daniel W., et al.
Publicado: (2018)

Muscarinic and Nicotinic Modulation of Thalamo-Prefrontal Cortex Synaptic Pasticity In Vivo
por: Bueno-Junior, Lezio Soares, et al.
Publicado: (2012)

Immunolocalization of muscarinic M1 receptor in the rat medial prefrontal cortex
por: Oda, Satoko, et al.
Publicado: (2018)

Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery
por: Cieślik, Paulina, et al.
Publicado: (2020)

Activity-dependent serotonergic excitation of callosal projection neurons in the mouse prefrontal cortex
por: Stephens, Emily K., et al.
Publicado: (2014)

Layer-specific serotonergic induction of long-term depression in the prefrontal cortex of rats
por: Shin, Dongchul, et al.
Publicado: (2020)

Trimethylamine N-oxide and the reverse cholesterol transport in cardiovascular disease: a cross-sectional study
por: Bordoni, Laura, et al.
Publicado: (2020)

Correction: Muscarinic and Nicotinic Modulation of Thalamo-Prefrontal Cortex Synaptic Plasticity In Vivo
por: Bueno-Junior, Lezio Soares, et al.
Publicado: (2012)

Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
por: Radulska, Adrianna, et al.
Publicado: (2023)

Mechanisms Underlying Serotonergic Excitation of Callosal Projection Neurons in the Mouse Medial Prefrontal Cortex
por: Stephens, Emily K., et al.
Publicado: (2018)

Gamma oscillations in somatosensory cortex recruit prefrontal and descending serotonergic pathways in aversion and nociception
por: Tan, Linette Liqi, et al.
Publicado: (2019)

A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze
por: Cieślik, Paulina, et al.
Publicado: (2023)

Neuromodulation of Persistent Activity and Working Memory Circuitry in Primate Prefrontal Cortex by Muscarinic Receptors
por: Vijayraghavan, Susheel, et al.
Publicado: (2021)

Corrigendum: Mechanisms Underlying Serotonergic Excitation of Callosal Projection Neurons in the Mouse Medial Prefrontal Cortex
por: Stephens, Emily K., et al.
Publicado: (2019)

Negative Allosteric Modulators of mGlu(7) Receptor as Putative Antipsychotic Drugs
por: Cieślik, Paulina, et al.
Publicado: (2018)

Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia
por: Maas, D A, et al.
Publicado: (2017)

Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex
por: Martin, Henry G. S., et al.
Publicado: (2015)

SELENBP1 overexpression in the prefrontal cortex underlies negative symptoms of schizophrenia
por: Kim, Soojin, et al.
Publicado: (2022)

18.1 MITOCHONDRIAL ALTERATIONS WITHIN THE PYRAMIDAL-PARVALBUMIN CELL MICROCIRCUIT IN THE PREFRONTAL CORTEX IN SCHIZOPHRENIA
por: Glausier, Jill
Publicado: (2018)

Twelve-hour rhythms in transcript expression within the human dorsolateral prefrontal cortex are altered in schizophrenia
por: Scott, Madeline R., et al.
Publicado: (2023)

Serotonergic Innervations of the Orbitofrontal and Medial-prefrontal Cortices are Differentially Involved in Visual Discrimination and Reversal Learning in Rats
por: Alsiö, Johan, et al.
Publicado: (2020)

Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images
por: Potvin, Stéphane, et al.
Publicado: (2017)

Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia
por: Hagihara, Hideo, et al.
Publicado: (2014)

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2015)

Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia
por: Bryois, Julien, et al.
Publicado: (2018)

Diurnal rhythms in gene expression in the prefrontal cortex in schizophrenia
por: Seney, Marianne L., et al.
Publicado: (2019)

Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia
por: Bilecki, Wiktor, et al.
Publicado: (2023)

Perturbed iron biology in the prefrontal cortex of people with schizophrenia
por: Lotan, Amit, et al.
Publicado: (2023)

Experimental Serotonergic Agents for the Treatment of Schizophrenia
por: Capuzzi, Enrico, et al.
Publicado: (2021)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023)

Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention
por: Tian, Michael K., et al.
Publicado: (2016)

Cell Type- and Layer-Specific Muscarinic Potentiation of Excitatory Synaptic Drive onto Parvalbumin Neurons in Mouse Prefrontal Cortex
por: Tikhonova, Tatiana B., et al.
Publicado: (2018)

Glutamatergic and Serotonergic Modulation of Rat Medial and Lateral Orbitofrontal Cortex in Visual Serial Reversal Learning
por: Hervig, Mona E., et al.
Publicado: (2020)

Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia
por: Guillozet-Bongaarts, A L, et al.
Publicado: (2014)

Decreased Chloride Channel Expression in the Dorsolateral Prefrontal Cortex in Schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o0aivuh3krp7n864snnn0342u7